Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Volcano launches rotational IVUS and FFR systems in USA and Europe

Volcano : 31 March, 2008  (New Product)
Volcano has launched the s5-Revo and s5-FFR (fractional flow reserve) options for the s5i integrated Imaging platform in the USA and Europe.
These two new product options now enable rotational IVUS and FFR to operate on the same integrated Volcano s5i Integrated Imaging System as Volcano's previous line of phased array IVUS catheters and functionality. For the first time, physicians can choose among three powerful diagnostic tools - all on the same integrated IVUS platform.

Scott Huennekens, president and chief executive officer of Volcano, commented, 'By adding high resolution rotational IVUS and pressure-based FFR to our already highly successful phased array s5 imaging platform, we will be providing a level of technology, clinical utility and convenience that is un-matched in the intravascular imaging field. No other company provides a system that integrates this level of functionality and convenience in a single platform. Our message now is simple: Volcano offers physicians all three technologies on one system - you can choose which technology is best for your patient and clinical team.'

Earlier generation consoles included only one of the three technologies now available on the s5i. If a hospital wanted to equip a new lab with all three technologies, they would have to acquire three separate consoles, each with a different measurement modality, training requirements and data storage protocols. The Volcano s5i can now accommodate the three primary intravascular diagnostic tools in regular use by cardiologists today (high frequency rotational IVUS, fast and simple phased array IVUS, and pressure-based FFR guidewires) on a single platform, making modern day imaging consoles more flexible than ever before.

Joe Burnett, associate vice president of marketing for Volcano, said, 'We believe that IVUS is one of the fastest growing market segments in interventional cardiology today. Our internal market model suggests that worldwide IVUS revenue grew approximately 15 percent in 2007. More and more physicians are augmenting their daily interpretation of angiography with this more exacting, precise technology. IVUS and FFR can provide objective measurements of lesion severity and Stent expansion, thus removing some of the inherent guess work surrounding 2D X-ray images. We believe that having these modalities available on a single integrated system can only further adoption of these important therapy guidance tools.'

As part of the s5-Revo and s5-FFR market introduction, Volcano is also launching Volcano TLC, a comprehensive on-site education programme available to current and future Volcano customers, targeted to increase IVUS and FFR awareness and build staff proficiency with these new integrated systems. Volcano TLC (Training and Learning Clinics) offers a combination of keynote speaker presentations, physician proctorships, hands-on system training, guided proficiency tools and workflow troubleshooting, all designed to optimise modern-day IVUS and FFR technology, and to allow physicians to acquire these precise diagnostic measurements in less time than ever before.

To kick-off the Volcano TLC programme, John Hodgson, MD, FSCAI will begin an 18 city speaking tour in the US and Canada. Dr Hodgson will deliver a 90-minute presentation and case review highlighting the essential role of IVUS and FFR in determining lesion severity and guiding proper Stent placement and expansion entitled ‘IVUS and FFR: More Important than Ever. A Guide to Optimal PCI on the Eve of Second Generation DES’.

Dr Hodgson commented, 'IVUS and FFR play an invaluable role in modern-day PCI. As practitioners, we are routinely misled by using angiography alone to assess lesion severity and confirm proper Stent placement. Although IVUS and FFR have long been available to augment angiography, legacy systems were cumbersome, and access to these systems was too limited to drive broader acceptance.'

Dr Hodgson continued, 'The combination of more complex target lesions, concerns about late Stent thrombosis, the launch of new faster, integrated IVUS and FFR technologies, and the growing awareness that angiography does not tell the whole story, has driven IVUS use dramatically higher in recent years. It is no wonder that the use of IVUS has increased so rapidly.'

The Volcano TLC speaker programme with Dr John Hodgson will visit the following cities over the next three months; New York City, Framingham, Buckhead, Miami, Baltimore, Nashville, Pittsburgh, Cleveland, Rosemont, Milwaukee, Houston, Dallas, Seattle, Las Vegas, San Francisco, Fresno, Montreal and Toronto.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo